These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 18426831

  • 21. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK, Zhang SF, Zou SE, Xia X, Xu LN.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [Abstract] [Full Text] [Related]

  • 22. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [Abstract] [Full Text] [Related]

  • 23. The insulin-resistant phenotype of polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L.
    Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
    [Abstract] [Full Text] [Related]

  • 24. Polycystic ovaries in Hirsute women with normal menses.
    Carmina E, Lobo RA.
    Am J Med; 2001 Dec 01; 111(8):602-6. PubMed ID: 11755502
    [Abstract] [Full Text] [Related]

  • 25. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul 01; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 26. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C, Arriaga M, Arechavaleta-Velasco F, Moran S.
    J Clin Endocrinol Metab; 2015 Mar 01; 100(3):942-50. PubMed ID: 25514100
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Mar 01; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 30. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S, Aydın S, Ozcan P, Soyman Z, Gokmen Karasu AF, Sevket O.
    J Obstet Gynaecol; 2018 Feb 01; 38(2):236-240. PubMed ID: 28920502
    [Abstract] [Full Text] [Related]

  • 31. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
    Tagliaferri V, Romualdi D, Guido M, Mancini A, De Cicco S, Di Florio C, Immediata V, Di Segni C, Lanzone A.
    Eur J Endocrinol; 2016 Nov 01; 175(5):433-41. PubMed ID: 27511825
    [Abstract] [Full Text] [Related]

  • 32. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun 01; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 33. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M, Azziz R, Beires J, Pignatelli D.
    Fertil Steril; 2010 Jul 01; 94(2):684-9. PubMed ID: 19726039
    [Abstract] [Full Text] [Related]

  • 34. Should insulin resistance be screened in lean hirsute women?
    Arduc A, Sarıcam O, Dogan BA, Tuna MM, Tutuncu YA, Isik S, Berker D, Sennaroglu E, Guler S.
    Gynecol Endocrinol; 2015 Apr 01; 31(4):291-5. PubMed ID: 25561024
    [Abstract] [Full Text] [Related]

  • 35. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 01; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 36. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
    Nezi M, Christopoulos P, Paltoglou G, Gryparis A, Bakoulas V, Deligeoroglou E, Creatsas G, Mastorakos G.
    J Pediatr Endocrinol Metab; 2016 Jun 01; 29(6):693-702. PubMed ID: 27089404
    [Abstract] [Full Text] [Related]

  • 37. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
    Ezeh U, Pisarska MD, Azziz R.
    Hum Reprod; 2022 Mar 01; 37(3):553-564. PubMed ID: 35048126
    [Abstract] [Full Text] [Related]

  • 38. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 01; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 39. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.
    JAMA Dermatol; 2016 Apr 01; 152(4):391-8. PubMed ID: 26720591
    [Abstract] [Full Text] [Related]

  • 40. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 01; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.